VIRGINIAMYCIN M1

VIRGINIAMYCIN M1 Suppliers list
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695
Email: factory@coreychem.com
Products Intro: Product Name:VIRGINIAMYCIN M1
CAS:21411-53-0
Purity:>=98% Package:1g;1USD
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:Virginiamycin M1;Ostreogrycin A;Pristinamycin IIA
CAS:21411-53-0
Purity:98.00% Package:100 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: BOC Sciences
Tel: 16314854226; +16314854226
Email: inquiry@bocsci.com
Products Intro: Product Name:Pristinamycin IIA
CAS:21411-53-0
Purity:>99% by HPLC Remarks:BOC Sciences also provides custom synthesis services for Pristinamycin IIA.
Company Name: Wuhan Topule Biopharmaceutical Co., Ltd
Tel: +8618327326525
Email: masar@topule.com
Products Intro: Product Name:Pristinamycin IIA
CAS:21411-53-0
Purity:98% Package:100mg;1g;500g Remarks:Topule Company operates with integrity and has its own laboratory, which supports packaging and customization. Payment will be made after the product has passed third-party testing
Company Name: Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
Tel: +86-19164747840 +86-13119157289
Email: 13119157289@163.com
Products Intro: Product Name:VIRGINIAMYCIN M1
CAS:21411-53-0
Purity:>=0.98 Package:G/bottle; Kg/bag; 25kg/barrel Remarks:in stock Purity: 99% | Package: As Buyer's Request

VIRGINIAMYCIN M1 manufacturers

  • VIRGINIAMYCIN M1
  • VIRGINIAMYCIN M1 pictures
  • $1.00 / 1g
  • 2019-12-26
  • CAS:21411-53-0
  • Min. Order: 1g
  • Purity: ≥98%
  • Supply Ability: g/kg/Ton
VIRGINIAMYCIN M1 Basic information
Product Name:VIRGINIAMYCIN M1
Synonyms:C11299;MikamycinA, Staphylomycin;Antibiotic PA-114A1;Pristinamycin IIA;Staphylomycin M1;Vernamycin A;VirginiaMycin M1 DISCONTINUED;MIKAMYCIN A
CAS:21411-53-0
MF:C28H35N3O7
MW:525.59
EINECS:244-376-6
Product Categories:antibiotic;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:21411-53-0.mol
VIRGINIAMYCIN M1 Structure
VIRGINIAMYCIN M1 Chemical Properties
Melting point 165-167℃
alpha D20 -218° ( c = 0.34 in ethanol)
Boiling point 825.2±65.0 °C(Predicted)
density 1.26±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility chloroform/methanol: soluble10mg/mL
form powder
pka13.18±0.70(Predicted)
color yellow to tan
Stability:Light Sensitive
Safety Information
WGK Germany 3
HS Code 29419090
MSDS Information
ProviderLanguage
SigmaAldrich English
VIRGINIAMYCIN M1 Usage And Synthesis
Chemical PropertiesLight yellow powder
UsesMacrolactone antibiotic. Antibacterial; growth promotant.
UsesOstreogrycin A (virginiamycin M1, streptogramin A) is the major component of the virginiamycin complex. In the 1950s this complex was independently discovered so many times that the literature became highly confusing. Ostreogrycin A is a macrocyclic lactone antibiotic that acts synergistically with the structurally unrelated cyclic depsipeptides, virginiamycin B (ostreogrycin B, streptogramin B) and virginiamycin S, to inhibit peptide elongation. This is achieved by blocking formation of a peptide bond between the growing peptide chain (peptidyl-tRNA) linked to the 50S ribosome and aminoacyl-tRNA. Ostreogrycin A is highly active against Gram positive bacteria, particularly MRSA.
UsesOstreogrycin A (virginiamycin M1, streptogramin A) is the major component of the virginamycin complex. In the 1950s this complex was independently discovered so many times that the literature became highly confusing. Ostreogrycin A is a macrocyclic lactone antibiotic that acts synergistically with the structurally unrelated cyclic depsipeptides, virginiamycin B (ostreogrycin B, streptogramin B) and virginiamycin S, to inhibit peptide elongation. This is achieved by blocking formation of a peptide bond between the growing peptide chain (peptidyl-tRNA) linked to the 50S ribosome and aminoacyl-tRNA. Ostreogrycin A is highly active against Gram positive bacteria, particularly MRSA.
DefinitionChEBI: A macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms includ ng methicillin-resistant Staphylococcus aureus.
Biological Activityvirginiamycin m1 is a macrolide antibiotic that reversibly inhibits protein synthesis [1][2][3].virginiamycin complex contains two antibiotics, virginiamycin m1 and virginiamycin s1. streptogramins are divided into class a and class b based on their structures. virginiamycin m1, also known as streptogramin a, is a member of the streptogramin a group of antibiotics, which bind the 50s ribosomal subunit at the peptidyl transferase center to inhibit initiation and translocation. they show good bactericidal activity against methicillin-resistant s. aureus (mrsa), although resistance in mrsa is conferred by the cfr gene. virginiamycin m1 has activity against gram-positive and in select cases gram-negative bacteria. combination of group a and b streptogramins exhibit bactericidal activity [1]. virginiamycin m1 acted synergistically with virginiamycin s1 to irreversibly inhibit protein synthesis in bacteria. in cell-free systems, virginiamycin m1 and virginiamycin s1 bound to the large ribosomal subunit, and the affinity of ribosomes for vs is increased by vm [2][3].
Contact allergensPristinamycin is a systemic antibiotic of the synergistins/ streptogramins class, composed of two subunits: pristinamycin IA and pristinamycin IIA. It induces several types of drug reactions such as maculo-papular exanthema, systemic dermatitis, or acute generalized exanthematous pustulosis. Some patients have been previously skin-sensitized by virginiamycin. Crossreactivity is expected to virginiamycin and to the associated dalfopristin and quinupristin.
Contact allergensLike the other streptogramin, pristinamycin, virginiamycin is made of two subunits, virginiamycin S1 and virginiamycin M1. Dermatitis was quite common in people using the formerly available topical virginiamycin. Occupational dermatitis was observed in the pharmaceutical industry, in breeders, and in a surgeon who used topical virginiamycin on postoperative wounds (personal observation).
references[1]. fair rj, tor y. antibiotics and bacterial resistance in the 21st century. perspect medicin chem. 2014 aug 28;6:25-64.
[2]. kehrenberg c, cuny c, strommenger b, et al. methicillin-resistant and -susceptible staphylococcus aureus strains of clonal lineages st398 and st9 from swine carry the multidrug resistance gene cfr. antimicrob agents chemother. 2009 feb;53(2):779-81.
[3]. parfait r, cocito c. lasting damage to bacterial ribosomes by reversibly bound virginiamycin m. proc natl acad sci u s a. 1980 sep;77(9):5492-6.
VIRGINIAMYCIN M1 Preparation Products And Raw materials
Tag:VIRGINIAMYCIN M1(21411-53-0) Related Product Information
PROCYANIDIN B2 Procyanidin B1 Procyanidin Pristinamycin IA VIRGINIAMYCIN M1 Methyl N,N-dimethylaminoacrylate Virginiamycin 5-(5-Hydroxy-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1,Virginiamycin S3 4-[N-Methyl-4-(methylamino)-L-phenylalanine]virginiamycin S1 4-L-Phenylalanine-5-(cis-4-hydroxy-L-2-piperidinecarboxylic acid) virginiamycin S1,Virginiamycin S2 Virginiamycin M2,(-)-Virginiamycin M2 Virginiamycin S1 virginiamycin butanolide C Virginiamycin S5 virginiamycin butanolide receptor virginiamycin butanolide D virginiamycin butanolide A Virginiamycin S4